Mechanistically, IL-1β spurs tumor growth by activating MAPK/NF-κB pathways, recruiting immunosuppressive cells, promoting inflammation, angiogenesis, invasion and metastasis, downregulating tumor suppressors, upregulating oncogenes, and enabling immune evasion and inhibition of apoptosis (45). Here, NFKB1 is linked to neoplasm.